This week FSA presents a quick comparison of two Asian high yield bond products: the Fidelity Asian High Yield Fund and the UBS Asian High Yield Fund.
Author Archives: Fund Selector Asia
Smartphones on wheels
There are parallels to be drawn between the growth and evolution of electric vehicles and smartphones, with attractive opportunities for savvy investors, according to Janus Henderson’s Global Technology Leaders team – Alison Porter, Graeme Clark and Richard Clode.
Mutual Fund Top Trumps – Europe ex-UK equities
his week FSA presents a quick comparison of two Europe ex-UK equity products: the Aberdeen Standard European Equity ex-UK Fund and the Blackrock Continental European Flexible Fund.
Turning environmental hopes into investment reality
By sharing revenue with carefully selected environmental charities, asset managers can have a tangible positive impact on environmental challenges, says TT International.
Mutual Fund Top Trumps – Emerging markets equity
This week FSA presents a quick comparison of two emerging markets equity products: the Amundi Emerging Markets Equity Focus Fund and the T. Rowe Price Emerging Markets Equity Fund.
Risks in Alternatives
As part of our Spotlight On: Alternatives, Fund Selector Asia spoke to our partners over a two-part series. This is part two, where we look at Risks in Alternatives in Asia.
Opportunities in Alternatives
As part of our Spotlight On: Alternatives, Fund Selector Asia spoke to our partners over a two-part series. This is part one, where we look at Opportunities in Alternatives in Asia.
Mutual Fund Top Trumps – Global High Yield Bonds
This week FSA presents a quick comparison of two global high yield bond funds: the JPM Global High Yield Bond Fund and the Pimco GIS Global High Yield Bond Fund.
Driving decarbonisation: how to access new forms of alpha
Climate change remains top of the agenda for many investors. But to make a meaningful dent, renewable energy, electrification and resource efficiency are three pathways to a low carbon future, says Ninety One.
Healthcare’s innovation shifts into high gear
Andy Acker, global life sciences portfolio manager, explores the unprecedented number of medical breakthroughs occurring in healthcare and what it means for the sector.
